Remedly
PrivateLast Round
Series A
Mar 9, 2021
Est. Valuation
$11.93M
Total Funding Raised
$6.24M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Remedly is a healthcare software company that provides an all-in-one, cloud-based platform combining Electronic Health Records (EHR), Revenue Cycle Management (RCM), and practice management solutions for specialty medical practices.
Sector
Enterprise Software
Verticals
Vertical SaaS, EHR & EMR, Patient Engagement, Revenue Cycle, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Remedly Comparables
Compare Remedly with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Prospyr Medical, Inc. | 91% | |
| Symplast | 91% | |
| Aesthetic Record | 90% |
Remedly Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 9, 2021 | ||||
| Series A | Oct 20, 2020 | ||||
| Seed | Mar 10, 2017 | ||||
| Accelerator | Mar 9, 2017 |
Remedly Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| StartX | Seed, Accelerator |
| FCA Venture Partners | Series A |
| Ulu Ventures | Series A |
| LEO Innovation Lab | Series A, Seed, Accelerator |
| Healthbox | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 16, 2026
Grew 25% QoQ, from 12 to 15 employees.
- Jun 23, 2026
Grew 25% QoQ, from 12 to 15 employees.
Remedly Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Remedly's valuation, stock price, and market status.
Is Remedly a public or private company?
Remedly is a private company.
What is the current stock price of Remedly?
Remedly is a private company, so its shares have no public market price. Caplight tracks Remedly's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Remedly worth (valuation)?
Remedly's valuation is estimated at $11.9M based on funding round data.
Can I buy Remedly stock?
Remedly shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Remedly's last funding round?
Remedly's most recent funding round was Series A on March 9, 2021.
Who are the main investors in Remedly?
Key investors in Remedly include LEO Innovation Lab.
Will Remedly IPO soon?
No public IPO plans have been announced for Remedly.
How can I track Remedly secondary market activity?
Caplight tracks bids, offers, and trades in Remedly's shares on secondary markets.